Is LogicBio Therapeutics Inc (LOGC) Stock a Bad Value Thursday?

Thursday, October 13, 2022 12:36 PM | InvestorsObserver Analysts

Mentioned in this article

Is LogicBio Therapeutics Inc (LOGC) Stock a Bad Value Thursday?

The 88 rating InvestorsObserver gives to LogicBio Therapeutics Inc (LOGC) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 100 percent of stocks in the Healthcare sector, LOGC’s 88 overall rating means the stock scores better than 88 of all stocks.

LOGC has an Overall Score of 88. Find out what this means to you and get the rest of the rankings on LOGC!

See Full LOGC Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With LogicBio Therapeutics Inc Stock Today?

LogicBio Therapeutics Inc (LOGC) stock is flat -0.25% while the S&P 500 has risen 1.45% as of 12:32 PM on Thursday, Oct 13. LOGC is flat $0.00 from the previous closing price of $2.04 on volume of 270,782 shares. Over the past year the S&P 500 is lower by -16.84% while LOGC has fallen -48.09%. LOGC lost -$0.16 per share the over the last 12 months. Click Here to get the full Stock Report for LogicBio Therapeutics Inc stock.